Tracers / [18F]F-PRGD2

[18F]F-PRGD2

Also written as [18F]F-PRGD2; [F-18]F-PRGD2
Radionuclide
F-18 t½ 109.77 min
Modality
PET
Production route
Stage
first-in-human
Syntheses indexed
3

What it is

Compound class
Dimeric RGD-peptide (PEG3-c(RGDyK)2 scaffold)
Target / mechanism
αvβ3 integrin expression PMID 21400112
Clinical application
PET imaging of αvβ3 integrin expression for detecting and monitoring tumor growth and metastasis PMID 21400112
Theranostic pair

Regulatory status

FDA
EMA (centralised)
Other approvals
Brand names

Clinical use

Typical injected activity
Uptake time

Reported in the literature. Not a dosing recommendation.

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
TRACERlab FX FN
GE HealthCare
custom manifoldHPLC+SPE16.9±2.7%
yes
>99%PEG3-c(RGDyK)2
Peptides International Inc.
21400112
2012 Mol Imaging Biol
a modified commercial radiosynthesis module (TRACERlab FXFN, GE Medical Systems) and a custommade module — [18F]FPP(RGD)2 was afforded with consistent RCYs (16.9±2.7%; n=8)
ca. 4%
no
PRGD229143364
2018 J Labelled Comp Radiopharm
use of the iPHASE Flexlab as an effective dual-stage radiochemical synthesis module — n.d.c. yields ca. 4% from fluoride
13% ± 3%
yes
>98%21267662
2011 Mol Imaging Biol
GE FASTlab™ synthesizer — d.c. yield of 13% ± 3% (n = 13) in 130 min

Need this precursor?We can point you to suppliers for [18F]F-PRGD2, or handle the enquiry for you.

Get in touch

Quality control Preliminary — inferred from compound class

Ph. Eur. monograph
USP monograph
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrityMolar activity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); receptor ligand with a saturable target -> molar activity (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]F-PRGD2.

Get in touch

Notes

Added from reverse module search (stage 6); 1 article(s) with F-18. Compound class inferred from precursor name (not stated outright) -- PMID 21400112: 'H-11-amino-3,6,9-trioxaundecanoic acid (AEEEA)-Glu[cyclo(Arg-Gly-Asp-d-Tyr-Lys)]2 (PEG3-c(RGDyK)2) (AEEEA, 99%), was purchased from Peptides International (USA).'. Stage set/updated at stage 23 from PMID 21400112: 'Imaging studies with [¹⁸F]FPP(RGD)₂ in normal mice and a healthy human volunteer were carried out using small animal and clinical PET scanners, respectively.'.